Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance - Wikidata - awgldk - TriplyDB

Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance

Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance

http://www.wikidata.org/entity/Q28279396

about

Sharpening Precision Medicine by a Thorough Interrogation of Metabolic Individuality Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application Essential roles of four-carbon backbone chemicals in the control of metabolism Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis.Understanding the Apothecaries Within: The Necessity of a Systematic Approach for Defining the Chemical Output of the Human Microbiome Metabolomic patterns and alcohol consumption in African Americans in the Atherosclerosis Risk in Communities Study Metabolomic Analysis Reveals Amino Acid Responses to an Oral Glucose Tolerance Test in Women with Prior History of Gestational Diabetes Mellitus.Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?Markers of tissue-specific insulin resistance predict the worsening of hyperglycemia, incident type 2 diabetes and cardiovascular disease.Effects of choline on health across the life course: a systematic review.Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.Novel metabolic markers for the risk of diabetes development in American Indians.Sex differences in biomarkers associated with insulin resistance in obese adolescents: metabolomic profiling and principal components analysis HCC development is associated to peripheral insulin resistance in a mouse model of NASH.High-fat diet-induced β-cell proliferation occurs prior to insulin resistance in C57Bl/6J male mice.A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study.GH Receptor Deficiency in Ecuadorian Adults Is Associated With Obesity and Enhanced Insulin Sensitivity A novel test for IGT utilizing metabolite markers of glucose tolerance.A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control Global metabolomic profiling targeting childhood obesity in the Hispanic population Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.Plasma metabolomic profiles enhance precision medicine for volunteers of normal health.Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC-ESI-MS/MS.A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.Biomarkers of Ectopic Fat Deposition: The Next Frontier in Serum Lipidomics.Metabolomics in childhood diabetes.Epigenetic associations of type 2 diabetes and BMI in an Arab population Conserved Metabolic Changes in Nondiabetic and Type 2 Diabetic Bariatric Surgery Patients: Global Metabolomic Pilot Study."Prediction is very hard, especially about the future": new biomarkers for type 2 diabetes?New insights into gestational glucose metabolism: lessons learned from 21st century approaches Metabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes A novel fasting blood test for insulin resistance and prediabetes.Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans.Type IV P-type ATPases distinguish mono- versus diacyl phosphatidylserine using a cytofacial exit gate in the membrane domain.Metabolic Networks and Metabolites Underlie Associations Between Maternal Glucose During Pregnancy and Newborn Size at Birth.Metabolomics reveals unexpected responses to oral glucose Profiling of plasma metabolites in postmenopausal women with metabolic syndrome Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model.Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profiling.

P2860

Q26765202-9A6263C9-F657-45FB-A84B-ABC7213D0947 Q26774386-779F6DAB-40E2-4284-B78B-F780A9ADD330 Q26795753-A71144CA-F6CF-48D0-B130-614BC102D76C Q31126519-4BFAA8CA-1302-4FF1-B991-DF4A101F6E6B Q33035147-E7C254F2-C6AD-4C1C-B5D3-8701D9B31242 Q33614788-6CCF556D-419B-4457-9C28-B4410C13B273 Q33738286-3494FB3F-212F-4317-BA11-2D96AD216BEC Q33887865-A5F93CD9-D7D6-4849-878C-261FA0D1760F Q34332137-C938A108-6618-4CD7-833B-87BB48510B71 Q34482202-0C8046C2-28C9-4E2D-A4EC-9AE78A329EB8 Q34527732-64ADC67E-DCCB-4A6C-A680-5BEC3BCB496B Q34996866-04C3C186-A5C3-499A-813A-670ED8889E04 Q35083344-BE06150C-8536-4AE3-A8E1-81C4CB5D6970 Q35172679-235A99D3-06F8-40A0-BCA7-699ED8DD7747 Q35273835-945C430F-09A6-489D-AF81-66A620259402 Q35578281-091A8785-912D-43D0-8696-CF80CEE39C1D Q35813235-AA79DEBE-B2E8-4072-B4A4-E33B80AD8EE1 Q35830440-03840D5B-DA58-4B52-87E6-DBBF0458009E Q35842441-3B6BA557-EBFE-4FF0-AD1D-6263A36012D5 Q35891508-4F423673-D136-4057-BBCD-B6B0502193C7 Q35919864-7A94CEE9-0B6A-468F-88DF-C5035CC3870E Q36055457-E3E9B2BF-EC8D-416A-A33C-DCEF928B28EB Q36062956-E8AC04A3-F7F8-4ABE-ACB2-76E192C08515 Q36279066-7A40104D-B1A9-4F2A-AC64-D62C79F9E433 Q36329899-EF1B8AFD-4EE0-4737-A207-4CE1F984D3DC Q36431633-C465959C-F9C5-4C95-B176-75E8BB29BF11 Q36436985-7F021DFD-12F2-4427-91FB-D8F89FB2F804 Q36513963-E03026B9-F807-433B-A41E-BC510916E252 Q36532009-B8D4E670-EF4C-4242-B029-15B12F4CBBF6 Q36796068-8031813A-30C3-4786-9DD1-472BC185A2D0 Q36926481-BA718EE3-8479-48DD-B826-942607494C27 Q36935538-049D8346-0E02-46D5-9DE5-221A1556E4EB Q36954280-D2A990A3-DB76-4EFB-810A-67DBBCCC2668 Q36999783-AFCDF6D1-1F07-40F4-9AF6-BCB4F9BC3E71 Q37000539-8B6E993D-B477-4F39-80C7-FF883C6D7A05 Q37025670-F57294F8-E3B7-4EC7-86E7-9452D1C03E81 Q37031082-8118C3B5-DEF1-4FB5-AEA9-0A489129717B Q37052539-F41382DD-82D1-4F65-85A9-2F739BEB829D Q37070820-1059C255-DB73-4E57-8E38-8BB4B52EE12D Q37279013-943E0569-F7BE-4472-8F32-900F7E565D02

P2860

Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance

http://www.wikidata.org/entity/Q28279396

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Early metabolic markers of the ...... eir physiological significance

@ast

Early metabolic markers of the ...... eir physiological significance

@en

Early metabolic markers of the ...... eir physiological significance

@nl

type

label

Early metabolic markers of the ...... eir physiological significance

@ast

Early metabolic markers of the ...... eir physiological significance

@en

Early metabolic markers of the ...... eir physiological significance

@nl

prefLabel

Early metabolic markers of the ...... eir physiological significance

@ast

Early metabolic markers of the ...... eir physiological significance

@en

Early metabolic markers of the ...... eir physiological significance

@nl

P1433

Q28279396-7511286E-B87E-4FDD-95A5-B50E907FFFD5

P1476

Q28279396-2B7CD76D-FA21-43CB-B5F1-D060454BB6F7

P2093

Q28279396-0E2B8902-F516-4A00-B780-32AE77DB79A7

Q28279396-5C7E7E78-1B07-41E0-8798-98AB0F774B5D

Q28279396-6F588702-F66E-4315-9928-53A9EEF3FA5C

Q28279396-965A581E-4E2E-49BA-B3BB-DF600587EF00

Q28279396-9A27E329-467E-4142-BE31-77354C6B0B4E

Q28279396-D9ED166A-F5CD-4819-A8F7-8DD8FADBE60B

P2860

Q28279396-0134AC86-5407-40DE-9C58-9F87B269DB1B

Q28279396-083183E2-1553-41B4-8952-E1CA3F151BBB

Q28279396-0B5815D2-B371-4306-B5AE-347FFEF028EB

Q28279396-26D2E883-3254-47F3-A17D-5E7EF5E401EF

Q28279396-2D92CAE8-7715-4A31-A97C-A572007D781B

Q28279396-32542A05-907E-4B1D-B258-358B8CBBAEB0

Q28279396-334B3778-23E7-4F0C-A5AE-E5C9CED128ED

Q28279396-3D940BEF-D7B4-4E6A-A98F-418B7463E00F

Q28279396-4B6DE832-D8EB-4DCF-A174-2219E64C9F9B

Q28279396-4C6977CA-A71F-4ECA-A78A-DD325734A319

P304

Q28279396-D50EDF3F-E5CF-446B-AF90-40381046BB58

P31

Q28279396-56443903-E34F-4DD1-9EA3-1F4A2A50C53C

P3181

Q28279396-28CA48AF-2C2A-4677-9AEF-982B15F000C8

P356

Q28279396-1D8F0E2D-B2E6-44BD-8B63-9581B1678E32

P407

Q28279396-1D14B374-8895-4F63-BCCE-229D4BDDAC29

P433

Q28279396-A4B71444-311F-4B6A-8CB1-ABA81776DC39

P478

Q28279396-72DA4F7F-B288-49BB-BB4D-B1E02B07FD66

P50

Q28279396-4D0F238B-E3C6-426B-B3DF-5EF63F287F6E

Q28279396-62D89B1C-1BF2-4052-9A11-59829CEECDC7

Q28279396-BF502902-6F34-47A9-A37B-BC4491420788

Q28279396-C1FF19E1-6C68-4DE0-8408-F510872B6713

Q28279396-E0EE721F-2FB4-44DB-BB73-4D0C0C266ED0

Q28279396-EA9F74E8-28FA-4D73-9E57-17FFBC4B4309

Q28279396-F7221267-1369-47A9-ABA4-31E7B1349FA6

P577

Q28279396-48722DA1-E2A6-4583-A7C9-6B9781DC3083

P5875

Q28279396-0B7CB6C1-9BCD-4D53-BC46-D9809532CABE

P698

Q28279396-2AD2BE8F-64E8-4A32-A40B-68D1FAF65F2B

P921

Q28279396-CAB586A9-5C63-4320-B689-53491710BB23

P932

Q28279396-5140BA9F-97E9-4D27-9D42-E819DE3F8F0B

P3181

P356

P1433

P1476

Early metabolic markers of the ...... eir physiological significance

@en

P2093

Andrea Mari

http://www.w3.org/2001/XMLSchema#string

Ele Ferrannini

http://www.w3.org/2001/XMLSchema#string

Jerzy Adamski

http://www.w3.org/2001/XMLSchema#string

Klaus-Peter Adam

http://www.w3.org/2001/XMLSchema#string

Michael V Milburn

http://www.w3.org/2001/XMLSchema#string

Walter E Gall

http://www.w3.org/2001/XMLSchema#string

P2860

alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Fatty acids, obesity, and insulin resistance: time for a reevaluation

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

Lysophosphatidylserine regulates blood glucose by enhancing glucose transport in myotubes and adipocytes

Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women

Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor

Metabolite profiles and the risk of developing diabetes

Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes.

Effect of insulin on system A amino acid transport in human skeletal muscle

P304

1730-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

806204

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DB12-0707

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Tiinamaija Tuomi

Valeriya Lyssenko

Stefania Camastra

Gabi Kastenmüller

Monica Nannipieri

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233537802

http://www.w3.org/2001/XMLSchema#string

P698

23160532

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3636608

http://www.w3.org/2001/XMLSchema#string